Canadian Population Serological Survey Utilizing Antenatal Serum Samples
The objectives of the Canadian Population Serological Survey Utilizing Antenatal Serum Samples are to:
* Provide an immediate cross-sectional assessment of the seroprevalence of antibodies to SARS-CoV-2 in Canada.
* Assess the retrospective evolution of SARS-CoV-2 prevalence; antenatal serology can be assessed going back one year thereby providing an opportunity to go back to where 0% prevalence is detected.
* Plan to perform periodic future seroprevalence based on the level of seroprevalence on the first cross-sectional assessment.
* Compare seroprevalence between Canadian provinces and territories.
Overview
- Acronym
- CPSS-Antenatal
- Investigators
-
- Contacts
-
General Design
- Study design
- Cross-sectional
- Start - End Year
- 2020 - 2021
- General Information on Follow Up (profile, frequency)
-
Periodic assessment of seroprevalence of SARS-CoV-2 utilizing clinically collected prenatal serology samples may be planned for future time points. The frequency and number of samples will be determined based on findings from the first cross-sectional assessment.
- Recruitment Target
-
- Individuals
- Number of Participants
- 18,000
- Supplementary information about number of participants
-
Cohort 1: 18,000 participants
Access
Availability of data and biosamples
| Possible Access to Data | |
| Possible Access to Biosamples | |
| Other |
|
Timeline
Populations
CPSS-Antenatal - Cohort 1
The population is composed of pregnant women in all provinces and territories of Canada who have their prenatal serology results available in laboratories.
Selection Criteria
- Gender
-
Women only
- Pregnant Women
-
- First trimester
- Countries
-
- Canada
- Canadian Provinces
-
- Alberta
- British Columbia
- Manitoba
- New Brunswick
- Newfoundland and Labrador
- Northwest Territories
- Nova Scotia
- Nunavut
- Ontario
- Prince Edward Island
- Quebec
- Saskatchewan
- Yukon
- Other Criteria
- Had a routine blood screening of the antibody status to rubella, HIV, Hepatits B and syphilis
Sources of Recruitment
- Specific Population
-
- Clinic patients
- Supplementary Information
-
Pregnant women who get a routine blood screening for prenatal care and who have their serological test results available for testing.
Sample Size
- Number of Participants
- 18,000
- Number of Participants with Biological Samples
- 18,000
Data Collection Events
| # | Name | Data sources | Data sources - Biosamples | Start | End |
|---|---|---|---|---|---|
| 0 | CPSS-Antenatal - Cohort 1 - Serotest |
|
|
2020 (November) | 2021 (March) |
CPSS-Antenatal - Cohort 2
The population is composed of pregnant women in all provinces and territories of Canada who have their antenatal screening for aneuploidy results available in laboratories.
Selection Criteria
- Gender
-
Women only
- Pregnant Women
-
- First trimester
- Second trimester
- Countries
-
- Canada
- Canadian Provinces
-
- Alberta
- British Columbia
- Manitoba
- New Brunswick
- Newfoundland and Labrador
- Northwest Territories
- Nova Scotia
- Nunavut
- Ontario
- Prince Edward Island
- Quebec
- Saskatchewan
- Yukon
- Other Criteria
- Had an aneuploidy blood screening
Sources of Recruitment
- Specific Population
-
- Clinic patients
- Supplementary Information
-
Pregnant women who get a routine blood screening for prenatal care and who have their aneuploidy test results data available for testing.
Data Collection Events
| # | Name | Data sources | Data sources - Biosamples | Start | End |
|---|---|---|---|---|---|
| 0 | CPSS-Antenatal - Cohort 2 - Retrospective survey |
|
|
2019 (December) | 2020 (December) |
Participating Studies
| Acronym | Name | Study design | Countries |
|---|
Harmonization Initiatives Included
| Acronym | Name |
|---|
Datasets
| Name | Data Collection Events | Variables |
|---|
Areas of Information Collected
- Socio-demographic and economic characteristics
- Death
- Lifestyle and behaviours
- Physical measures and assessments
- Birth, pregnancy and reproductive health history
- Laboratory measures
- Perception of health, quality of life, development and functional limitations
- Cognition, personality and psychological measures and assessments
- Diseases
- Life events, life plans, beliefs and values
- Symptoms and signs
- Preschool, school and work life
- Medication and supplements
- Social environment and relationships
- Non-pharmacological interventions
- Physical environment
- Health and community care services utilization
- Administrative information
Variables Content Summary
Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected
Networks
| Acronym | Name | Harmonization Initiatives | Individual Studies |
|---|
Last Update: 2024-02-27T12:09:39.733